Editorial Board
Nicola Squillace Specialization in Infectious Diseases (Università degli Studi di Modena e Reggio Emilia Facoltà di Medicina e Chirurgia); Medicine and Surgery (Seconda Università degli Studi di Napoli Dipartimento Multidisciplinare di Specialità Medico-Chirurgiche e Odon
Infectious Diseases' Specialist, Azienda Socio Sanitaria Territoriale di Monza, Monza, Lombardia · Italy
Editorial leadership for International Journal of Cytokine
Research interests
- Management Of Hiv Infection
- Hiv-Related Comorbidities: Antiretroviral Treatment -Related Adverse Events
- Metabolic Abnomalities (Dyslipidemia
- Insulin Resistance
- Diabetes
- Cardiovascular Risk)
- Immune-Activation
- Inflammation
- Risk Of Cancer
- Hpv Related Malignancies
- Non Alcoholic Fatty Liver Disease
Biography
- Degree in Medicine attained 28th March of 2000 at the Faculty of Medicine and Surgery of the Second University of Naples with thesis about “Antiretroviral therapy in subjects infected by HIV and HCV”
- Professional certificate : qualfying examination attained at Ist General Hospital of Naples (“I Policlinico”, Second University of Naples) in December 2000.
- Specialized in Infectious diseases on 11th November 2005 at University of Modena and Reggio Emilia .
- From November 2005 to September 2008 He had been working as HIV specialist at the Metabolic Clinic of the University of Modena for management and treatment of HIV related lipodystrophy. Since October 2008 employed as Infectious Diseases Specialist at “San Gerardo” Hospital of Monza, Infectious Disease Unit. Research programs.
- Reviewer for: BMC infectious diseases, PlosONE, AIDS Research and Human Retroviruses, Infection, Medicine, Microbial Pathogenesis.
- Language skills ENGLISH : upper-intermediate level certified by FCE attained in December 2007 International Scholarships 2006 Scholarship recipient for the partecipation to the "8th International workshop on Adverse Drug Reactions and Lipodystrophy in HIV” 24-26 September 2006 San Francisco USA 2007 Scholarship recipient for the partecipation to the’4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention” 22-25 July 2007, Sydney, Australia
Selected publications
- The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile 2020 cited 34×
- Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project 2019 cited 28×
- Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a decade 2021 cited 19×
- Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 2017 cited 15×
- Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen: Data from a Real-Life Setting 2023 cited 14×
- Nonalcoholic fatty liver disease and steatohepatitis in people living with HIV 2019 cited 14×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering IJCY for your work?
This journal is guided by Nicola Squillace (Infectious Diseases' Specialist, Azienda Socio Sanitaria Territoriale di Monza, Monza, Lombardia) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.